Joint Formulary & PAD

GP

Guideline Profile : Dementia

Committee Recommendations (1)

The APC approved the local guidance for the use of acetylcholinesterase inhibitors (AChE I) and memantine in the treatment of Alzheimer's Disease, Dementia with Lewy Body, Vascular Dementia and Parkinson's Dementia. See agreed treatment pathway below

The local guidance has been based on NICE NG97 Dementia: assessment, management and support for people living with dementia and their carers. See document below'

Guideline Profile

Indication :
Dementia
Keywords :
AChE Inhibitors, acetylcholinesterase inhibitors, alzheimers disease, alzheimers dementia, Alzheimer's disease, Lewy Body dementia, Lewy bodies, Vascular dementia, Parkinson's dementia, Frontotemporal dementia
Brand Names Include :
donepezil, Aricept, memantine, rivastigmine, galantamine, Reminyl, Acumor, Galsya, Ebixa, Exelon, Alzhok, Marixino, Nemdatine, Valios, Almuriva, Alzest, Nimvastid, Prometax, Voleze, Consion, Galzemic, Gatalin, Lotprosin, Luventa
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Supporting Documents :
5